Long intergenic non-protein coding RNA 1901 (LINC01901)

Long intergenic non-protein coding RNA 1901 (LINC01901) is a long intergenic non-coding RNA (lincRNA), classified as a member of non-coding RNAs longer than 200 nucleotides that do not overlap annotated protein-coding genes[1][3][5]. LincRNAs, including LINC01901, are characterized by their lack of protein-coding potential and are often involved in fine-tuning gene expression through mechanisms such as chromatin remodeling, modulation of transcription, RNA stabilization, and epigenetic regulation[1][3][5]. These functions may be sequence-dependent or sequence-independent and can exhibit remarkable tissue specificity[1]. While some lincRNAs have been associated with cellular processes such as cell growth, division, and epigenetic modification—and a fraction are implicated in diseases (notably cancer)—there is currently no specific published evidence linking LINC01901 to therapeutic targeting, disease states, drug interactions, or biomarker roles. LINC01901, like most lincRNAs, is not considered a therapeutic target (e.g., not a receptor, enzyme, transporter), and its biological and clinical relevance remains to be determined on the basis of new research[1][3][5].

Other names

LINC01901long intergenic non-coding RNA 1901